Myasthenia Gravis Subtypes
David P. Randall, DO, Director of Neuromuscular Neurology/ Advocate Medical Group, explains how myasthenia gravis is classified by antibodies, age, presence of a thymoma, and other features. This, in turn, defines most effective treatment choices.
▶︎
Emerging Therapies for Myasthenia Gravis
▶︎
Reprogramming the Immune System to Halt MG | Webinar with COUR
▶︎
2018 MG Conference: Remission – What, Why, How 14
▶︎
Myasthenia Gravis: Eating to Combat Prednisone Weight Gain
▶︎
Variants of GBS|CIDP, Speaker Series
▶︎
Myasthenia Gravis & Exercise
▶︎
2018 MG Conference - Crisis/ Emergency Management
▶︎
Christopher Morgan, MD: Sleep Apnea and MG
▶︎
New and Emerging Treatments for Myasthenia Gravis
▶︎
Eating to Fine-tune Your Immune System - with Conquer MG
▶︎
Seronegative MG with Dr. Allan Weiss and the MGA
▶︎
MGFA Webinar Series: Know Your Antibodies
▶︎
Webcast: Clinical Tipping Points In Portal Hypertension Virtual Broadcast
▶︎
Generalized Myasthenia Gravis: Targeted Novel Therapies to Improve Patient Outcomes
▶︎
Antineoplastic Agents | Clinical Medicine
▶︎
Professional Education: Emergency Management of Myasthenia Gravis: Overview for First Responders
▶︎
CNS Infections | Clinical Medicine
▶︎
JRowin: Functional Medicine Approach to Myasthenia Gravis
▶︎
Therapeutic Approaches with Subtypes of Myasthenia Gravis
▶︎